{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:02:13Z","timestamp":1772578933301,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/bf03347516","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T22:48:02Z","timestamp":1397170082000},"page":"742-746","source":"Crossref","is-referenced-by-count":15,"title":["Vascular endothelial growth factor (VEGF), prostaglandin E2 (PGE2) and active renin in hypertension of adrenal origin"],"prefix":"10.1007","volume":"27","author":[{"given":"S.","family":"Zacharieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Atanassova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Orbetzova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kirilov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nachev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kalinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Shigarminova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03347516_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jemt.10256","volume":"60","author":"R Katoh","year":"2003","unstructured":"Katoh R. Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor. Microsc Res Tech 2003, 60: 181\u20135.","journal-title":"Microsc Res Tech"},{"key":"BF03347516_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T. The biology of vascular endothe-lial growth factor. Endocr Rev 1997, 18: 4\u201325.","journal-title":"Endocr Rev"},{"key":"BF03347516_CR3","first-page":"H586","volume":"256","author":"DD Ku","year":"1993","unstructured":"Ku DD, Zaleski JK, Liu SY, Brock TA. Vascular endothelial growth factor induced EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993, 256: H586\u201392.","journal-title":"Am J Physiol"},{"key":"BF03347516_CR4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/01.CIR.95.4.1030","volume":"95","author":"R Zee Van der","year":"1997","unstructured":"Van der Zee R, Murohara T, Luo Z, et al. Vascular endothelial growth factor\/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation 1997, 95: 1030\u20137.","journal-title":"Circulation"},{"key":"BF03347516_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/jsre.1996.0226","volume":"63","author":"MD Hariawala","year":"1996","unstructured":"Hariawala MD, Horowitz JR, Esakof D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 1996, 63: 77\u201382.","journal-title":"J Surg Res"},{"key":"BF03347516_CR6","first-page":"I","volume":"92","author":"J Horowitz","year":"1995","unstructured":"Horowitz J, Hariawala M, Sheriff DD, Keyt B, Symes JF. In vivo administration of vascular endothelial growth factor is associated with EDRF-dependent decrease in systemic hypotension in porcine and rabbit. Circulation 1995, 92: I\u2013630 (abstract).","journal-title":"Circulation"},{"key":"BF03347516_CR7","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00005344-199606000-00011","volume":"27","author":"R Yang","year":"1996","unstructured":"Yang R, Thomas G, Bunting S, et al. Effects of vascular endothelial growth factor on hemodynamic and cardiac performance. J Cardiovasc Pharmacol 1996, 27: 838\u201344.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"SupplA","key":"BF03347516_CR8","first-page":"37A","volume":"35","author":"SM Eppler","year":"2000","unstructured":"Eppler SM, McCluskey ER, Henry TD, Simons M, Giordano FJ, Zioncheck TF. Unique kinetics and hemodynamics of vascular endothelial growth factor (rhVEGF) following in-tracoronary and intravenous infusion in humans. J Am Coll Cardiol 2000, 35 (Suppl A): 37A (abstract).","journal-title":"J Am Coll Cardiol"},{"key":"BF03347516_CR9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0022-3565(24)38756-7","volume":"296","author":"M-H Liu","year":"2001","unstructured":"Liu M-H, Jin H, Floten S, et al. Vascular endothelial growth factor-mediated endothelium-dependent relaxation is blunted in spontaneously hypertensive rats. J Pharmacol Exp Ther 2001, 296: 473\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03347516_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9149(00)01512-5","volume":"87","author":"FM Belgore","year":"2001","unstructured":"Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, Lip GY. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 2001, 87: 805\u20137.","journal-title":"Am J Cardiol"},{"key":"BF03347516_CR11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1006\/bbrc.2001.5494","volume":"286","author":"R Pai","year":"2001","unstructured":"Pai R, Szabo IL, Soreghan BA, Atay S, Kawanaka H, Tarnaw-ski AS. PGE(2) stimulates VEGF expression in endothelial cells via ERK2\/JNK1 signaling pathways. Biochem Biophys Res Commun 2001, 286: 923\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03347516_CR12","first-page":"325","volume":"31","author":"E Fosslien","year":"2001","unstructured":"Fosslien E. Review: molecular pathology of cyclooxyge-nase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 2001, 31: 325\u201348.","journal-title":"Ann Clin Lab Sci"},{"key":"BF03347516_CR13","doi-asserted-by":"crossref","first-page":"H885","DOI":"10.1152\/ajpheart.2001.280.2.H885","volume":"280","author":"O Saijonmaa","year":"2001","unstructured":"Saijonmaa O, Nyman T, Kosonen R, Fyhrquist F. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol 2001, 280: H885\u201391.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BF03347516_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1681\/ASN.V102245","volume":"10","author":"C Pupilli","year":"1999","unstructured":"Pupilli C, Lasagni L, Romagnani P, et al. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor\/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 1999, 10: 245\u201355.","journal-title":"J Am Soc Nephrol"},{"key":"BF03347516_CR15","doi-asserted-by":"crossref","first-page":"H885","DOI":"10.1152\/ajpheart.2001.280.2.H885","volume":"280","author":"O Saijonmaa","year":"2001","unstructured":"Saijonmaa O, Nyma T, Kosonen R, Fyhrquist F. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol 2001, 280: H885\u201391.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BF03347516_CR16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03349761","volume":"18","author":"RD Gordon","year":"1995","unstructured":"Gordon RD. Primary aldosteronism. J Endocrinol Invest 1995, 18: 495\u2013511.","journal-title":"J Endocrinol Invest"},{"key":"BF03347516_CR17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2174\/1381612033454540","volume":"9","author":"FN Kiefer","year":"2003","unstructured":"Kiefer FN, Neysari S, Humar R, Li W, Munk VC, Battegay EJ. Hypertension and angiogenesis. Curr Pharm Des 2003, 9: 1733\u201344.","journal-title":"Curr Pharm Des"},{"key":"BF03347516_CR18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/hc3101.091158","volume":"104","author":"BI Levy","year":"2001","unstructured":"Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 2001, 104: 735\u201340.","journal-title":"Circulation"},{"key":"BF03347516_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0895-7061(02)03149-7","volume":"16","author":"DC Felmeden","year":"2003","unstructured":"Felmeden DC, Spencer CG, Belgore FM, Blann AD, Beevers DG, Lip GY. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens 2003, 16: 11\u201320.","journal-title":"Am J Hypertens"},{"key":"BF03347516_CR20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2796.2003.01087.x","volume":"253","author":"DC Felmeden","year":"2003","unstructured":"Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY. Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Intern Med 2003, 253: 81\u201391.","journal-title":"J Intern Med"},{"key":"BF03347516_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-4804(02)00042-2","volume":"109","author":"A Cucina","year":"2003","unstructured":"Cucina A, Borrelli V, Randone B, Coluccia P, Sapienza P, Cavallaro A. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J Surg Res 2003, 109: 16\u201323.","journal-title":"J Surg Res"},{"key":"BF03347516_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jemt.10256","volume":"60","author":"R Katoh","year":"2003","unstructured":"Katoh R. Angiogenesis in endocrine glands: special reference to the expression of vascular endothelial growth factor. Microsc Res Tech 2003, 60: 181\u20135.","journal-title":"Microsc Res Tech"},{"key":"BF03347516_CR23","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1210\/jc.2001-011799","volume":"87","author":"GP Bernini","year":"2002","unstructured":"Bernini GP, Moretti A, Bonadio AG, et al. Angiogenesis in human normal and pathologic adrenal cortex. J Clin Endo-crinol Metab 2002, 87: 4961\u20135.","journal-title":"J Clin Endo-crinol Metab"},{"key":"BF03347516_CR24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0002-9440(10)64400-8","volume":"161","author":"J Favier","year":"2002","unstructured":"Favier J, Plouin PF, Corvol P, Gasc JM. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 2002, 161: 1235\u201346.","journal-title":"Am J Pathol"},{"key":"BF03347516_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1034\/j.1600-0463.2003.1110402.x","volume":"111","author":"K Salmenkivi","year":"2003","unstructured":"Salmenkivi K, Heikkila P, Liu J, Haglund C, Arola J. VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome. APMIS 2003, 111: 458\u201364.","journal-title":"APMIS"},{"key":"BF03347516_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jemt.10333","volume":"61","author":"M Thomas","year":"2003","unstructured":"Thomas M, Keramidas M, Monchaux E, Feige JJ. Role of adrenocorticotropic hormone in the development and maintenance of the adrenal cortical vasculature. Microsc Res Tech 2003, 61: 247\u201351","journal-title":"Microsc Res Tech"},{"key":"BF03347516_CR27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/07435800009048610","volume":"26","author":"P Heikkila","year":"2000","unstructured":"Heikkila P, Arola J, Voutilainen R, Salmenkivi K, Kahri AL, Liu J. Expression of vascular endothelial growth factor in human adrenals. Endocr Res 2000, 26: 867\u201371.","journal-title":"Endocr Res"},{"key":"BF03347516_CR28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/1097-4652(200011)185:2<226::AID-JCP7>3.0.CO;2-E","volume":"185","author":"I Gaillard","year":"2000","unstructured":"Gaillard I, Keramidas M, Liakos P, Vilgrain I, Feige JJ, Vit-tet D. ACTH-regulated expression of vascular endothelial growth factor in the adult bovine adrenal cortex: a possible role in the maintenance of the microvasculature. J Cell Physiol 2000, 185: 226\u201334.","journal-title":"J Cell Physiol"},{"key":"BF03347516_CR29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jemt.10262","volume":"60","author":"S Yamada","year":"2003","unstructured":"Yamada S, Takada K. Angiogenesis in pituitary adenomas. Microsc Res Tech 2003, 60: 236\u201343.","journal-title":"Microsc Res Tech"},{"key":"BF03347516_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.0.1480203","volume":"148","author":"JA Hunter","year":"2003","unstructured":"Hunter JA, Skelly RH, Aylwin SJ, et al. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas. Eur J Endocrinol 2003, 148: 203\u201311.","journal-title":"Eur J Endocrinol"},{"key":"BF03347516_CR31","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1182\/blood-2002-11-3400","volume":"102","author":"R Salcedo","year":"2003","unstructured":"Salcedo R, Zhang X, Young HA, et al. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood 2003, 102: 1966\u201377.","journal-title":"Blood"},{"key":"BF03347516_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","volume":"112","author":"K Egami","year":"2003","unstructured":"Egami K, Murohara T, Shimada T, et al. Role of host an-giotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003, 112: 67\u201375.","journal-title":"J Clin Invest"},{"key":"BF03347516_CR33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI118838","volume":"98","author":"OV Volpert","year":"1996","unstructured":"Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996, 98: 671\u201379.","journal-title":"J Clin Invest"},{"key":"BF03347516_CR34","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0008-6363(01)00372-8","volume":"52","author":"S Takeshita","year":"2001","unstructured":"Takeshita S, Tomiyama H, Yokoyama N, et al. Angiotensin converting enzyme inhibition improves defective angiogen-esis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 2001, 52: 314\u201320.","journal-title":"Cardiovasc Res"},{"issue":"Suppl1","key":"BF03347516_CR35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000173950","volume":"72","author":"W Tenschert","year":"1985","unstructured":"Tenschert W, Baumgart P, Greminger P, Vetter W, Vetter H. Pathogenetic aspects of hypertension in Cushing\u2019s syndrome. Cardiology 1985, 72 (Suppl 1): 84\u201390.","journal-title":"Cardiology"},{"key":"BF03347516_CR36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem-62-2-275","volume":"62","author":"T Saruta","year":"1986","unstructured":"Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S. Multiple factors contribute to the pathogenesis of hypertension in Cushing\u2019s syndrome. J Clin Endocrinol Metab 1986, 62: 275\u20139.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347516\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T10:09:46Z","timestamp":1746180586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BF03347516"],"URL":"https:\/\/doi.org\/10.1007\/bf03347516","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}